Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury
Sponsor: Peking Union Medical College Hospital
Summary
In patients with multiple myeloma-related acute kidney injury, compare the renal outcome of chemotherapy combined with HFR-SUPRA to chemotherapy combined with hemodialysis.
Official title: Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury: a Prospective Cohort Study
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2022-07-01
Completion Date
2032-12-01
Last Updated
2022-06-23
Healthy Volunteers
No
Conditions
Interventions
HFR-SUPRA
HFR-SUPRA everyday for 3 days, then 3 times/week until patients do not require dialysis.
hemodialysis
hemodialysis everyday for 3 days, then 3 times/week until patients do not require dialysis.
Chemotherapy
chemotherapy protocol will be made by hematologists.